Mumbai
4th April, 2025: India is at the cusp of a major health
crisis as obesity rates surge across all age groups, driving an alarming rise
in early mortality linked to diabetes, cardiovascular diseases, and cancer. As
per the National Family Health Survey (NFHS-5), nearly 24% of women and 22.9%
of men are now classified as obese.
The Good Bug, a pioneering gut health brand
in India, has launched a path breaking scientific innovation poised to disrupt
the weight loss landscape. The Good Bug’s Advanced Metabolic
System is the latest advancement in natural GLP-1 science
offering a sustainable & science-backed solution to weight loss. The
breakthrough has been scientifically validated with clinical trial data showing
a 12.01% reduction in weight, 9.64% decrease in waist circumference, and 12.14%
reduction in BMI in 90 days.
Keshav
Biyani, Co-founder of The Good Bug, stated, "Developed through cutting-edge gut microbiome research,
the Advanced Metabolic System is a proprietary blend of clinically tested
probiotics and prebiotics solving for obesity through Natural GLP-1
activation —without the adverse side effects commonly associated with
weight-loss drugs. With the launch of this product, validated through
scientific clinical trials, we are proud to offer a global first-of-its-kind
innovative solution that delivers upto 12% weight loss in 90 days. As pioneers
in gut health, we identified disbalance in gut biome composition to be the
fundamental root cause behind obesity and put together years of R&D to
build a solution that could eventually help increase GLP-1 and GIP naturally to
deliver weight loss outcomes. This is a big scientific breakthrough for us
which has been discovered, developed and made in India, and will redefine
weight management globally.”
Unlike pharmaceutical GLP-1 agonists, which
are commonly associated with side effects and dependency, The Good Bug's
Advanced Metabolic System naturally increases GLP-1 levels in the body, reduces
chronic inflammation in the Gut, thereby regulating appetite and reducing
cravings to deliver sustainable weight & health outcomes. Trusted
by healthcare professionals, it offers a sustainable and natural approach to
weight management. The Good Bug plans to take this product to the global
markets including the US.
Dr.
M.K.N. Manohar, Senior Consultant at Manipal Hospitals, and the trial’s
principal investigator shared, “In
the Clinical trials conducted, The results were not only statistically
significant but also clinically meaningful. It is comparable to the best of the
drugs what is available as of now,” he affirms. “What stood out was the
self-reported drop in cravings and improved satiety. Over 90% said their
cravings had reduced; 95% noted hunger suppression. This mirrors what’s seen
with synthetic GLP-1 drugs,” he explains. “Importantly, no significant adverse
events were reported. And the trials showed clear improvements in appetite,
satiety, and energy levels.”
He further added, “Obesity has become
a silent pandemic, accelerated by COVID. There is a wide gap between lifestyle
changes and invasive treatments like surgery. Scientific evidence increasingly
highlights the gut microbiome as a cornerstone of metabolic health and
sustainable weight management. Unlike synthetic interventions that often come
with unintended side effects, a well-researched probiotic formulation like The
Good Bug leverages the natural synergy between gut bacteria and the body’s
metabolism.”
Available at ₹2000 per month or ₹5000 for
three months, The Good Bug’s solution is accessible via online platforms and
retail stores. With its focus on research-driven efficacy and transparency, The
Good Bug is redefining the role of gut health in overall well-being.
Prabhu
Karthikeyan, Co-founder of The Good Bug, stated, “We recognize microbiome science's impact not only on digestive
health but also on metabolic health, women’s health, and cognitive well-being.
As research into the microbiome deepens, it unfolds a new dimension of
healthcare and we remain committed to leveraging its potential. We strive to
continuously build consumer health solutions through advanced probiotic
innovation, empowering individuals to take control of their health through
science-driven products. We see a big opportunity in how our new launch can
impact the obesity landscape in the country."
Obesity has emerged as a major health
concern, in lieu of which Hon'ble Prime Minister Narendra Modiji recently
launched an anti-obesity drive. According to data from the Indian Council of
Medical Research (ICMR), over 180 million Indians were classified as overweight
or obese in 2021, and studies predict this number could surge to 400 million by
2050. This further highlights the urgent need for effective, clinically proven,
and affordable solutions like The Good Bug.
Founded in 2022 by Keshav Biyani and Prabhu
Karthikeyan, The Good Bug is dedicated to transform gut health through a
science-backed, honest, and transparent approach. The brand's mission is to
make gut health simple, accessible, and help everyone take control of their
wellness journey. Their extensive range includes clinically tested synbiotic
formulas, probiotics, prebiotic fibers, a 14-day Detox formula, and our new
Ferments collection featuring kombuchas, water kefirs, and fermented pickles.
Designed for both adults and kids, the products combine powerful yet gentle
natural ingredients with bacterial strains validated by multiple studies to
support digestive health and overall well-being. With every product, the brand
empower everyone to take charge of their health and wellness.